The emerging treatment of the medication represents a exciting breakthrough in the care of type 2 diabetes. Different to existing drugs, tirzepatide impacts two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide993666.review-blogger.com/63643096/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment